Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer
Clinical trial NCT03316599 · COMPLETED
Trial details
- NCT number
- NCT03316599
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-17
- Primary completion
- 2020-10-10
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.